发明名称 |
COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO, AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING BLOOD GLP-1 LEVEL |
摘要 |
PROBLEM TO BE SOLVED: To provide a new approach in lowering a blood glucose level or in increasing a blood GLP-I level in a subject. SOLUTION: The present invention concerns combination of an amount of a GPR1 19 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-I level in a subject over that provided by the amount of the GPR1 19 agonist or the amount of the DPP-FV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions are ameliorated by increasing a blood GLP-I level. The present invention also relates to the use of a G protein-coupled receptor to screen for GLP-I secretagogues. COPYRIGHT: (C)2008,JPO&INPIT
|
申请公布号 |
JP2008220375(A) |
申请公布日期 |
2008.09.25 |
申请号 |
JP20080068598 |
申请日期 |
2008.03.17 |
申请人 |
ARENA PHARMACEUTICALS INC |
发明人 |
CHU ZHI-LIANG;LEONARD JAMES N;AL-SHAMMA HUSSIEN A;JONES ROBERT M |
分类号 |
C12Q1/02;A61K31/444;A61K31/4985;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/08;A61P9/10;A61P9/12;A61P25/00;A61P25/14;A61P25/16;A61P25/28;A61P27/12;A61P43/00;C07D401/12;C07D487/04;C12N15/09;C12Q1/48;G01N33/15;G01N33/50 |
主分类号 |
C12Q1/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|